News
-
WHO Online Course: Good Practices for Clinical Trial Design and Implementation
The World Health Organization (WHO) launches a free, online, self-paced online course on ‘Good Practices for Clinical Trial Design and Implementation’. Designed to provide a comprehensive understanding of the factors that contribute to trial quality, the course covers five key scientific and ethical principles for designing and conducting high-quality clinical trials.
-
PROPHET project presents SRIA and Roadmap on Personalised Prevention
On 26-27 March, the Coordination and Support Action (CSA) PROPHET presented the results of its work: a Strategic Research and Innovation Agenda (SRIA) and a Roadmap for Personalised Prevention.
-
EATRIS Policy Brief on European Regulatory Frameworks in the Context of Personalised Medicine
EATRIS has published a new policy brief that examines how current European regulatory frameworks are shaping personalised medicine. The brief is the result of collaboration across the EATRIS distributed network and partners active in personalised medicine.
-
Survey on Genomic Medicine Training for Healthcare Professionals
For the widespread implementation of genomics in healthcare to benefit patients and improve the efficiency of health services, adequate training of health professionals in genomic medicine is key. To this end, the Genomic Data Infrastructure (GDI) project has developed an international survey on genomic medicine training for healthcare professionals.
Showcasing Impactful Research and Collaborations in Personalised Medicine
The EP PerMed success stories highlight the remarkable achievements and outcomes of projects funded under EP PerMed & ERA PerMed. These stories demonstrate the tangible impact of research in personalised medicine, from groundbreaking scientific discoveries to advancements in clinical practice, innovative methodologies, and collaborations that drive progress in healthcare.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.